Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Expands By 125.0%

Posted by Defense World Staff on Mar 14th, 2025

Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 900 shares, a growth of 125.0% from the February 13th total of 400 shares. Based on an average trading volume of 5,700 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the company are sold short.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC raised its position in Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Free Report) by 200.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 61,342 shares of the company’s stock after acquiring an additional 40,924 shares during the quarter. Jane Street Group LLC owned approximately 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 at the end of the most recent quarter.

Fidelity Disruptive Medicine ETF Stock Down 1.5 %

Shares of FMED stock opened at $23.59 on Friday. The company has a 50 day moving average price of $25.52 and a 200-day moving average price of $25.71. Fidelity Disruptive Medicine ETF has a 52 week low of $23.32 and a 52 week high of $26.79. The firm has a market capitalization of $49.54 million, a PE ratio of 42.34 and a beta of 0.94.

Fidelity Disruptive Medicine ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 24th. Shareholders of record on Friday, December 20th were given a $0.112 dividend. This represents a $0.45 dividend on an annualized basis and a yield of 1.90%. The ex-dividend date was Friday, December 20th. This is an increase from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00.

About Fidelity Disruptive Medicine ETF

(Get Free Report)

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.